Atlas Trials

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism

Clinical trial NCT00891670 · UNKNOWN

Trial details

NCT number
NCT00891670
Sponsor
Gyeongsang National University Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Coronary Artery StenosisMaximal Platelet AggregationLate Platelet AggregationHigh Post-Treatment Platelet Reactivity
Start date
2009-05-01
Primary completion
2009-06-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.